EP4043466
PRC2 INHIBITORS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
29.1.2019EP published:
21.8.2024EP application number:
22165237.3
EPO information:
European Patent Register
Max expiry date:
28.1.2039
Title in English:
PRC2 INHIBITORSLanguage of the patent:
English
Timeline
Today
29.1.2019EP application
21.8.2024EP Publication
Owner
Name:
Mirati Therapeutics, Inc.Address:
3545 Cray Court, San Diego, CA 92121, US
Inventor
Name:
MARX, Matthew, ArnoldAddress:
San Diego 92127, US
Name:
LEE, Matthew, RandolphAddress:
Del Mar 92014, US
Name:
BOBINSKI, Thomas, P.Address:
San Diego 92122-4647, US
Name:
BURNS, Aaron, CraigAddress:
San Diego 92128, US
Name:
ARORA, NidhiAddress:
San Diego 92130, US
Name:
CHRISTENSEN, James, GailAddress:
San Diego 92130, US
Name:
KETCHAM, John. MichaelAddress:
San Diego 92111, US
Priority
Number:
201862624176 PDate:
31.1.2018Country:
US
Number:
201862672701 PDate:
17.5.2018Country:
US
Number:
201862747736 PDate:
19.10.2018Country:
US
Classification
Categories:
C07D 487/04, A61P 35/00, A61K 31/519